Molecular scissors help cancer cells break out and spread

September 29, 2006

A University of Michigan research team has identified how cancer cells employ a sort of molecular scissors to cut their way out of tumors and begin spreading throughout the body.

This spread of cancer cells, called metastasis, marks a turning point in the progression of the disease, after which treatment and recovery become more difficult.

"We asked how cancer cells cut their way through tissues," said Stephen Weiss, Life Sciences Institute research professor and division chief, molecular medicine and genetics in the U-M Medical School. "They use what we call proteases, a type of molecular scissors. However, there are so many different types of these scissors encoded by the human genome, we wanted to focus our attention on finding the subset used by cancers."

In all forms of cancer, a hallmark of malignancy is the tumor's ability to penetrate the basement membrane, a specialized connective tissue that lines the internal and external surfaces of the body including blood vessels, nerves, muscle and fat. Of the more than 500 enzymes that could be used by cells as molecular scissors, the Weiss team found that three proteases, termed MT1-MMP, MT2-MMP and MT3-MMP, are the most likely candidates that regulate cancer cell invasion.

The tumor cells appear to use these three enzymes to cut their way through the basement membrane, thus allowing cancer cells access to blood vessels which act as conduits for the spread of malignant cells to distant sites in the body.

"These closely related proteases allow cancer cells to start eating through basement membranes and the surrounding tissues," Weiss said. "This is the first critical step in the malignant process and allows the rapid spread of cancer cells through the body."

By identifying this set of proteases, the studies by Weiss and his colleagues have provided the first known proof that a small set of genes and proteins may underlie the cancer cell metastatic process. While their work is still at an early stage, the researchers are attempting to develop new inhibitors of these proteases so that they could test their importance in animal models of human cancer.

"A cancer cell metalloprotease triad regulates the basement membrane transmigration program," by Kevin Hotary, Xiao-Yan Li, Edward Allen, Susan L. Stevens and Stephen J. Weiss, appears as an advanced online publication in the journal Genes & Development and in print on Oct. 1, 2006.

Source: University of Michigan

Explore further: Candidate drug may be effective against broader class of brain cancers

Related Stories

Candidate drug may be effective against broader class of brain cancers

July 9, 2018
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor (EGFR), a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed ...

Alternative splicing is crucial to muscle mass maintenance

July 10, 2018
Despite the importance that changes in muscle mass have in aging, overall body metabolism and in chronic disease, we still don't fully understand the mechanisms that contribute to the maintenance of adult muscle mass.

Researchers identify enzyme linked to prostate cancer

December 18, 2012
Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic ...

Virus shows promise as prostate cancer treatment

February 25, 2013
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...

HIV drug shows efficacy in treating mouse models of HER2+ breast cancer

October 6, 2012
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the ...

How killer immune cells avoid killing themselves

June 9, 2011
After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success. The findings published online on June 9th in Immunity offer an explanation for how specialized immune ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.